Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins - Scorecard - MDSpire

Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

  • By

  • Vikrama Raja

  • Carlos Aguiar

  • Nasreen Alsayed

  • Yogeyaa S. Chibber

  • Hussein ElBadawi

  • Michel Farnier

  • Kumari Pushpa

  • Lale Tokgözoglu

  • Alberto Zambon

  • Jean-Pascal Berrou

  • Michel P. Hermans

  • June 4, 2026

  • 0 min

Share

Clinical Scorecard: Addressing Remnant Cholesterol: The Impact of Fenofibrate-Statin Combination Therapy on Triglyceride-Rich Lipoproteins

At a Glance

CategoryDetail
Condition
Key MechanismsRemnant cholesterol (RC) as a contributor to atherosclerotic cardiovascular disease (ASCVD) risk.
Target Population
Care Setting

Key Highlights

  • Remnant cholesterol (RC) is an independent risk factor for ASCVD.
  • Statin therapy may not fully mitigate RC-related residual cardiovascular risk.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider fenofibrate in combination with statins for patients with elevated triglycerides and residual risk.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Fenofibrate is well tolerated.

        Clinical Best Practices

        • Focus on lowering non-HDL-C and ApoB.

        Related Resources & Content

        Original Source(s)

        Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

        • by Vikrama Raja, Carlos Aguiar, Nasreen Alsayed, Yogeyaa S. Chibber, Hussein ElBadawi, Michel Farnier, Kumari Pushpa, Lale Tokgözoglu, Alberto Zambon, Jean-Pascal Berrou, Michel P. Hermans

        • June 4, 2026

        Related Content

        Top 10 States With Rising Demand for Physicians

        These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

        Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study

        Side Effects: They Googled It

        Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.